Global Alcohol Addiction Therapeutics Market By Product Type (5-HT3 Receptor Antagonist, Antidotes, Others), By End User (Hospital Pharmacies, Retail Pharmacies, Rehabilitation Centers), and Region - Global Forecast to 2030

“Global Alcohol Addiction Therapeutics Market” is the title of recently published market report compiled by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global alcohol addiction therapeutics market has been segmented on the basis of product type, end-user, as well as regions and countries.

Request Covid - 19 Impact

The Global Alcohol Addiction Therapeutics Market was valued at UЅD $884 Мn in 2020, and is projected to achieve a valuation of UЅD $1,498.3 Мn by 2030, at a САGR of 6.5%.

Overview:

Alcohol addiction therapeutics refers to the various forms of treatment options that are given to individuals who suffer from Alcohol Use Disorder (AUD), including detoxification, behavior modification, counseling and medication.

Dynamics:

The growing awareness among individuals concerning the numerous disadvantages to the excessive consumption of alcohol such as liver inflammation, high, blood, pressure, the development of a host of cancers like stomach, liver, colon, breast, and mouth, is a primary factor that is expected to continue to fuel the revenue growth of the global alcohol addiction therapeutics market over the next 10 years.

Moreover, the exponential increase in the number of alcohol-related deaths, especially in recent years, is another primary factor that is slated to play a pivotal role in boosting the demand for alcohol addiction therapeutic products, thereby significantly influencing future market growth opportunities in the process.

However, in light of the recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global alcohol addiction therapeutics market is no different, and is a factor that is expected to have a significantly negative impact on the revenue growth of this industry in the coming years.

Additionally, the ease in the availability of alcohol across the globe, and the lax enforcement of adequate regulations to prevent its abuse are some other factors that are expected to have a negative impact on the market growth of this global industry in the near future.

Nonetheless, numerous initiatives being undertaken by key market players as well as governing bodies to improving access to alcohol addiction therapeutics, and to increase awareness levels concerning the benefits of responsible alcohol consumption are also other factors that are anticipated to positively influence market growth prospects for the global alcohol addiction therapeutics market in the foreseeable future.

Segmentation of the global alcohol addiction therapeutics market is as follows:

In terms of type, the others segment accounted for the maximum number of revenue shares of the global alcohol addiction therapeutics market in 2020, and is expected to continue doing so over the forecast period. The 5-HT3 receptor antagonist segment is also anticipated to register a considerable CAGR over the next 10 years.

With regards to end-user, the hospital pharmacies segment accounted for the highest number of revenue shares of the global alcohol addiction therapeutics market in 2020. The retail pharmacies segment is also expected to register considerable revenue growth in the years to come.

Regional Segmentation and Analysis:

North America accounted for the maximum number of revenue shares of the global alcohol addiction therapies market in 2020, and is expected to index a high CAGR over the remainder of this forecast period. However, the markets in the Asia Pacific region are anticipated to register the highest CAGR over the next 10 years.

Segmentation of the Global Alcohol Addiction Therapeutics Market:

Segmentation by Product Type:

• 5-HT3 Receptor Antagonist
• Antidotes
• Others

Segmentation by End-User:

• Hospital Pharmacies
• Retail Pharmacies
• Rehabilitation Centers
• Other End-Users

Segmentation by Regions:

• North America
• Europe
• APAC
• South America
• MEA

• Cipla Limited
• GlaxoSmithKline plc
• Henry Schein, Inc.
• Merck & Co. Inc.
• Sun Pharmaceutical Industries Ltd
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• Mylan (Apicore US LLC)
• Noramco GmbH
• Kinnov-Therapeutics
• Chronos Therapeutics Limited
• Bionex Pharmaceuticals LLC
• Curemark LLC